LIMITED AGENCY AGREEMENTLimited Agency Agreement • February 27th, 2023
State of , hereafter designated as “Agent”, and “PIA Pacific Northwest Service Corporation,” hereafter designated as “Company”.
WITNESSETH:Limited Agency Agreement • April 13th, 2004 • Tamarack Funds Trust • Pennsylvania
Subject: Limited Agency AgreementLimited Agency Agreement • July 10th, 2017
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Shenzhen Chuangwei-RGB Electronics Co., Ltd.Limited Agency Agreement • October 30th, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Zhongshan City Richsound Electronic Industrial Ltd.Limited Agency Agreement • January 31st, 2024
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Shenzhen Fitcare Electronics Co., LtdLimited Agency Agreement • June 1st, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
GG-GG-EE6F-JDT-20-1004 Federal Communications Commission 445 12th Street SW Washington, DC 20554 Subject: Limited Agency AgreementLimited Agency Agreement • October 8th, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Anker Innovations LimitedLimited Agency Agreement • March 23rd, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Urbanista ABLimited Agency Agreement • November 12th, 2019
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Subject: Limited Agency AgreementLimited Agency Agreement • July 1st, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Tristar Products, Inc .Limited Agency Agreement • February 5th, 2021
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Shantou Chenghai Huabo Smart Living Technology Co.,LTDLimited Agency Agreement • June 16th, 2023
Subject: Limited Agency AgreementLimited Agency Agreement • January 8th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Washington, DC 20554 Subject: Limited Agency AgreementLimited Agency Agreement • April 22nd, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
SKY WING Communication Electronics Co.,LtdLimited Agency Agreement • January 8th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Washington, DC 20554 Subject: Limited Agency AgreementLimited Agency Agreement • May 29th, 2019
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
SUNVALLEYTEK INTERNATIONAL, INC.Limited Agency Agreement • August 2nd, 2017
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Shantou Xinyu Industry Co., Ltd.Limited Agency Agreement • April 11th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Subject: Limited Agency AgreementLimited Agency Agreement • November 21st, 2019
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Guoguang Electric Co.,LtdLimited Agency Agreement • April 27th, 2022
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Jiefeng Trading(Shenzhen)Co., Ltd. Room 8C70, 8th Floor, Block A, 8th Floor, Commercial Building, Xinghua Building, 2018 Shennan Zhong Road, Fuqiang Community, Huaqiang North Street, Futian District, ShenzhenLimited Agency Agreement • August 6th, 2019
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
FOUSINE (HONG KONG) INDUSTRIAL HOLDINGS LIMITEDLimited Agency Agreement • April 20th, 2021
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Dongguan UiiSii Electronics Co., Ltd.Limited Agency Agreement • February 26th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Subject: Limited Agency AgreementLimited Agency Agreement • December 22nd, 2017
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
APPENDIX BLimited Agency Agreement • September 25th, 2020
Shenzhen MZJ Technology Co., LimitedLimited Agency Agreement • October 14th, 2019
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Federal Communications Commission 445 12th Street SW Washington, DC 20554 Subject: Limited Agency AgreementLimited Agency Agreement • June 29th, 2022
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Jiangmen Dascom Computer Peripherals Co.,Ltd.Limited Agency Agreement • September 12th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
ContractLimited Agency Agreement • July 12th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Zhong Wang Wireless Earphone Co.，LimitedLimited Agency Agreement • July 28th, 2022
Anker Innovations LimitedLimited Agency Agreement • May 6th, 2020
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
MPOW Technology Co., Ltd.Limited Agency Agreement • December 21st, 2017
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Shenzhen Feasycom Technology Co.,LTDLimited Agency Agreement • July 3rd, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Shenzhen Kean Digital Co., Ltd.Limited Agency Agreement • January 16th, 2018
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Subject: Limited Agency AgreementLimited Agency Agreement • November 13th, 2019
This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
